Fantastic Blog, thank you ~Prof Neveen.
People in their middle age, as Sharon Moe is, see middle age crisis everywhere...others dont define issues in such terms instead they choose less age-defining labels, such as the one you employ...yet to mature...personally, I agree with you...Nephrology has stagnated for the last 50-100 years...BP control and proteinuria (since Richard Bright 1830s...) and steroids for the last 50 years or more....+/_ few advances here and there...mainly in renal transplantation...that is only 60 years old...
so Nephrology is a baby...that needs to move to a mature adulthood...rather than an ageing middle life crisis adult...Genetics...Genetic engineering...Molecular Engineering...will cure diseases like PKD we still treat by controlling BP...and hypertension...
You are spot on...but then you are a pediatrician....that thinks everybody has to grow...as children do...![;)]( ";)")
People in their middle age, as Sharon Moe is, see middle age crisis everywhere...others dont define issues in such terms instead they choose less age-defining labels, such as the one you employ...yet to mature...personally, I agree with you...Nephrology has stagnated for the last 50-100 years...BP control and proteinuria (since Richard Bright 1830s...) and steroids for the last 50 years or more....+/_ few advances here and there...mainly in renal transplantation...that is only 60 years old...
so Nephrology is a baby...that needs to move to a mature adulthood...rather than an ageing middle life crisis adult...Genetics...Genetic engineering...Molecular Engineering...will cure diseases like PKD we still treat by controlling BP...and hypertension...
You are spot on...but then you are a pediatrician....that thinks everybody has to grow...as children do...
Thank yo for your comment Professor El Nahas.
I might disagree with ASN president in labeling the current nephrology status as a middle age crisis, nevertheless I admire the new path that she and the ASN Board are bravely taking despite the hurdles. The key talks in the Kidney week with huge audience (no parallel sessions) are only a proof to the new vision of reinvigorating nephrology through supporting innovations in basic and translational research.
I might disagree with ASN president in labeling the current nephrology status as a middle age crisis, nevertheless I admire the new path that she and the ASN Board are bravely taking despite the hurdles. The key talks in the Kidney week with huge audience (no parallel sessions) are only a proof to the new vision of reinvigorating nephrology through supporting innovations in basic and translational research.
